150 related articles for article (PubMed ID: 16542366)
1. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
[TBL] [Abstract][Full Text] [Related]
2. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.
Hoppu S; Härkönen T; Ronkainen MS; Akerblom HK; Knip M;
J Autoimmun; 2004 Dec; 23(4):361-70. PubMed ID: 15571930
[TBL] [Abstract][Full Text] [Related]
3. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
4. Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.
Richardson CC; McLaughlin KA; Morgan D; Feltbower RG; Christie MR
Diabetologia; 2016 Feb; 59(2):334-40. PubMed ID: 26564179
[TBL] [Abstract][Full Text] [Related]
5. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen.
Kolm-Litty V; Berlo S; Bonifacio E; Bearzatto M; Engel AM; Christie M; Ziegler AG; Wild T; Endl J
J Immunol; 2000 Oct; 165(8):4676-84. PubMed ID: 11035111
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody 76F distinguishes IA-2 from IA-2beta and overlaps an autoantibody epitope.
Piquer S; Valera L; Lampasona V; Jardin-Watelet B; Roche S; Granier C; Roquet F; Christie MR; Giordano T; Malosio ML; Bonifacio E; Laune D
J Autoimmun; 2006 May; 26(3):215-22. PubMed ID: 16503116
[TBL] [Abstract][Full Text] [Related]
8. Fine mapping of diabetes-associated IA-2 specific autoantibodies.
Bearzatto M; Lampasona V; Belloni C; Bonifacio E
J Autoimmun; 2003 Dec; 21(4):377-82. PubMed ID: 14624760
[TBL] [Abstract][Full Text] [Related]
9. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens.
Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E
J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
[TBL] [Abstract][Full Text] [Related]
12. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
14. Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM.
Hatfield EC; Hawkes CJ; Payton MA; Christie MR
Diabetologia; 1997 Nov; 40(11):1327-33. PubMed ID: 9389426
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.
Horváth L; Cervenak L; Oroszlán M; Prohászka Z; Uray K; Hudecz F; Baranyi E; Madácsy L; Singh M; Romics L; Füst G; Pánczél P
Immunol Lett; 2002 Mar; 80(3):155-62. PubMed ID: 11803047
[TBL] [Abstract][Full Text] [Related]
16. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes.
Kawasaki E; Sera Y; Fujita N; Yamauchi M; Ozaki M; Abe T; Yamakawa K; Uotani S; Takino H; Yamasaki H; Yamaguchi Y; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 2001 Dec; 17(4):323-31. PubMed ID: 11771957
[TBL] [Abstract][Full Text] [Related]
17. IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes.
Seissler J; Eikamp K; Schott M; Scherbaum WA;
Horm Metab Res; 2002 Apr; 34(4):186-91. PubMed ID: 11987027
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
19. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Mäkinen A; Härkönen T; Ilonen J; Knip M;
Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
